TrialClinical pharmacology in drug development2020

Pharmacokinetic Similarity of ABP 710, a Proposed Biosimilar to Infliximab: Results From a Randomized, Single-Blind, Single-Dose, Parallel-Group Study in Healthy Subjects.

Vincent Chow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.